Shoulder Innovations initiated with an Overweight at Piper Sandler

Piper Sandler analyst Matt O’Brien initiated coverage of Shoulder Innovations (SI) with an Overweight rating and $18 price target The company competes in the $2B shoulder replacement market, providing “unique” anatomic and reverse total shoulder arthroplasty implants that provide better clinical outcomes with a less capital-intensive business model relative to peers, the analyst tells investors in a research note. Piper believes Shoulder Innovations can see above-market revenue growth and further share capture in the years to come.